DrugPatentWatch Database Preview
Profile for Israel Patent: 189136
US Patent Family Members and Approved Drugs for Israel Patent: 189136
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 22, 2022 | Novo Nordisk Inc | SAXENDA | liraglutide recombinant |
➤ Sign Up | Aug 22, 2022 | Novo Nordisk Inc | VICTOZA | liraglutide recombinant |
➤ Sign Up | Aug 22, 2022 | Novo Nordisk Inc | XULTOPHY 100/3.6 | insulin degludec; liraglutide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |